A number of antivascular endothelial growth factor agents are currently available to treat
various ocular conditions. These agents have similar, but distinct, biologic qualities and …

OBJECTIVES: To describe conjunctiva and Tenon's capsule handling during the Port
Delivery System with ranibizumab (PDS) implant insertion procedure including up-front …

Несмотря на впечатляющие достижения современной фармакотерапии глаукомы, не
все формы и стадии этого заболевания поддаются медикаментозному лечению. И в …

Glaucoma Drainage Device Erosions in Patients Receiving Anti-Vascular Endothelial Growth
Factor Therapy for Diabetic Retinopathy - PMC Back to Top Skip to main content NIH NLM …

Purpose To determine the rates of primary and recurrent glaucoma tube shunt erosions in
patients with age-related macular degeneration (AMD) receiving anti-vascular endothelial …

Abstract Purpose of Review Toxicological and pharmacological exposures may accelerate
or impede wound healing and tissue repair. These exposures impact the wound healing …

Filtration surgery has, for the past 50 years been key in the treatment of glaucoma yet a
significant issue in the long-term success of such surgery is fibrosis limiting aqueous …

A chemotherapeutic drug exerts favorable antitumor activity and simultaneously exhibits
expectable inhibition on wound healing process. Phenanthroimidazole derivatives possess …

Excessive scarring in the area of hypotensive glaucoma surgery is still a challenge in
ophthalmology as it is the main cause of postoperative IOP elevation. The antiproliferative …

An effective filtering bleb contributes resistance to aqueous humor outflow, thereby
preventing hypotony, and blocks ingress of microorganisms. Bleb formation after glaucoma …